NEW YORK (GenomeWeb News) –The fundraising organization Stand Up To Cancer (SU2C) has provided a grant of €6 million ($8.1 million) to investigators at the Dutch Cancer Society and the American Association for Cancer Research to fund an effort to grow and study living tumors from patient samples and to use them in studies of possible drug candidates.

SU2C said today the Dream Team grant will provide four years of funding to establish and develop a "living biobank" of tumor organoids using a technique that the principal investigators developed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The partially reinstated US travel ban leaves space for uncertainty for researchers, Nature News says.

Researchers find a number of traits differ by sex and could affect mouse model studies, according to Reuters.

Tweaking the skin microbiome could help address some skin conditions, the New York Times reports.

In PNAS this week: DNA methylation profiles of tumor tissue, gene dynamics in prokaryotes, and more.

Jul
19
Sponsored by
Philips Genomics

This webinar will provide an overview of how liquid biopsies can be integrated into lung cancer care.

Jul
20
Sponsored by
NuGEN

This webinar describes the characterization of gene fusions across distinct subtypes of melanoma.